International Journal of Dermatology

Article	Citations
Chilblain‐like lesions on feet and hands during the COVID‐19 Pandemic	133
Leukocytoclastic vasculitis flare following the COVID‐19 vaccine	84
Herpes zoster in COVID‐19‐positive patients	82
Keloids: a review of therapeutic management	65
Global burden of psoriasis – comparison of regional and global epidemiology, 1990 to 2017	61
New‐onset leukocytoclastic vasculitis after COVID‐19 vaccine	54
Telogen effluvium: a sequela of COVID‐19	50
Effects of hydrolyzed collagen supplementation on skin aging: a systematic review and meta‐analysis	44
Multidrug‐resistant Trichophyton mentagrophytes genotype VIII in an Iranian family with generalized dermatophytosis: report of four cases and review of literature	42
The “Maskne” microbiome – pathophysiology and therapeutics	41
Low‐dose oral minoxidil as treatment for non‐scarring alopecia: a systematic review	38
SARS‐CoV‐2 vaccine‐related cutaneous manifestations: a systematic review	38
Scabies outbreak during COVID‐19: an Italian experience	34
Herpes zoster ophthalmicus in COVID‐19 patients	32
COVID‐19: association with rapidly progressive forms of alopecia areata	32
Diet and acne: review of the evidence from 2009 to 2020	31
Covid‐19 pandemic and the skin	29
Clinical characteristics of dermatologic manifestations of COVID‐19 infection: case series of 15 patients, review of literature, and proposed etiological classification	28
Impact of the COVID‐19 pandemic on hospital admissions of patients with rare diseases: an experience of a Southern Italy referral center	28
Impact of delay in follow‐up due to COVID‐19 pandemic on skin cancer progression: a real‐life experience from an Italian hub hospital	28
Dermatologic manifestations of COVID‐19: a comprehensive systematic review	27
Measuring fatigue: a meta‐review	27
Minor aphthae associated with SARS‐CoV‐2 infection	27
Pityriasis rosea after mRNA COVID‐19 vaccination	27
Oral vesicles and acral erythema: report of a cutaneous manifestation of COVID‐19	26

Cold atmospheric pressure (physical) plasma in dermatology: where are we today?	24
The emergence of Trichophyton indotineae: Implications for clinical practice	24
Dowling‐Degos disease: a review	24
Scleromyxedema treatment: a systematic review and update	24
Dermatological manifestations of Epstein‐Barr virus systemic infection: a case report and literature review	24
International recommendations for an effective control of head louse infestations	23
Urticarial vasculitis in a COVID‐19 recovered patient	23
TYK 2 inhibitors for the treatment of dermatologic conditions: the evolution of JAK inhibitors	23
Annular lichen planus associated with coronavirus SARS‐CoV‐2 disease (COVID‐19)	23
Chronic spontaneous urticaria exacerbation in a patient with COVID‐19: rapid and excellent response to omalizumab	23
Dermoscopy of discoid lupus erythematosus – a systematic review of the literature	22
Atopic dermatitis in the elderly Caucasian population: diagnostic clinical criteria and review of the literature	22
Diffuse cutaneous manifestation in a new mother with COVID‐19 (SARS‐Cov‐2)	22
Skin manifestations in COVID‐19 patients, state of the art. A systematic review	22
The prevalence, risk factors, and psychosocial impacts of acne vulgaris in medical students: a literature review	21
Alopecia areata following COVID‐19 vaccination: vaccine‐induced autoimmunity?	21
International Dermoscopy Society criteria for non‐neoplastic dermatoses (general dermatology): validation for skin of color through a Delphi expert consensus	21
COVID‐19 and nail manifestation: be on the lookout for the red half‐moon nail sign	21
A comparative study of topical 5% cysteamine versus 4% hydroquinone in the treatment of facial melasma in women	21
“Fake news” in dermatology. Results from an observational, cross‐sectional study	21
Alterations in mental health and quality of life in patients with skin disorders: a narrative review	20
Review of smartphone mobile applications for skin cancer detection: what are the changes in availability, functionality, and costs to users over time?	20
Isotretinoin in the management of acne vulgaris: practical prescribing	20
Follicular mucinosis: a review	20
Dermoscopy of acquired pigmentary disorders: a comprehensive review	19
Dermoscopy in differential diagnosis of inflammatory dermatoses and mycosis fungoides	19
Chilblain‐like lesions during the COVID‐19 pandemic: should we really worry?	19
Dupilumab treatment ameliorates clinical and hematological symptoms, including blood eosinophilia, in patients with atopic dermatitis	19
Infection risk of dermatologic therapeutics during the COVID‐19 pandemic: an evidence‐based recalibration	19
Cutaneous T‐cell lymphoma following dupilumab use: a systematic review	18
Atypical erythema multiforme related to BNT162b2 (Pfizer–BioNTech) COVID‐19 vaccine	18
The clinical significance of fungi in atopic dermatitis	18
Validation of CP‐GEP (Merlin Assay) for predicting sentinel lymph node metastasis in primary cutaneous melanoma patients: A U.S. cohort study	18
Long‐term results of the treatment of primary hyperhidrosis with oxybutynin: follow‐up of 1,658 cases	18
Hydroxyurea: a reappraisal of its cutaneous side effects and their management	17
COVID‐19 vaccination: possible short‐term exacerbations of oral mucosal diseases	17
High prevalence of cryofibrinogenemia in patients with chilblains during the COVID‐19 outbreak	17
A concomitant diagnosis of COVID‐19 infection and systemic lupus erythematosus complicated by a macrophage activation syndrome: A new case report	17
Clinical and onychoscopic characteristics of subungual glomus tumor: a cross‐sectional study	17
COVID‐19‐related oral mucosa lesions among confirmed SARS‐CoV‐2 patients: a systematic review	17
Treatment of hidradenitis suppurativa with certolizumab pegol during pregnancy	17
Widespread cutaneous small vessel vasculitis secondary to COVID‐19 infection	17
COVID‐19: a possible trigger for oral lichen planus?	17
Exogenous ochronosis associated with hydroquinone: a systematic review	17
Impact of the COVID‐19 pandemic on the diagnosis of new leprosy cases in Northeastern Brazil, 2020	17
Concurrent chronic alopecia areata and severe atopic dermatitis successfully treated with upadacitinib	16
The increasing problem of treatment‐resistant fungal infections: a call for antifungal stewardship programs	16
Climate change, the cutaneous microbiome and skin disease: implications for a warming world	16
The trend of cutaneous lesions during COVID‐19 pandemic: lessons from a meta‐analysis and systematic review	16
Acral chilblain‐like lesions following inactivated SARS‐CoV‐2 vaccination	16

COVID‐19 “second wave” and vaccines: the dermatologists’ perspective	16
Comprehensive approach to managing hidradenitis suppurativa patients	15
Treatment of melasma: a review of less commonly used antioxidants	15
Metabolic syndrome and hidradenitis suppurativa: epidemiological, molecular, and therapeutic aspects	15
Erosive pustular dermatosis of the scalp: causes and treatments	15
COVID‐19: An overview for dermatologists	15
A case of morphea following the COVID‐19 mRNA vaccine: on the basis of viral spike proteins	15
Safety of Janus kinase (JAK) inhibitors in the short‐term treatment of atopic dermatitis	15
Climate change, human migration, and skin disease: is there a link?	15
Terra firma‐forme dermatosis: a systematic review	15
Dermatological side effects rarely interfere with the continuation of checkpoint inhibitor immunotherapy for cancer	14
Treatment of hidradenitis suppurativa with tetracycline, doxycycline, or lymecycline: a prospective study	14
Efficacy and safety of Jessner’s solution peel in comparison with salicylic acid 30% peel in the management of patients with acne vulgaris and postacne hyperpigmentation with skin of color: a randomiz	14
Management of skin thinning and aging: review of therapies for neocollagenesis; hormones and energy devices	14
Squamous cell carcinoma arising within hidradenitis suppurativa: a literature review	14
Stevens‐Johnson syndrome and toxic epidermal necrolysis associated with the use of macrolide antibiotics: a review of published cases	13
SARS‐Coronavirus‐2 and acute urticaria	13
Hidradenitis suppurativa: pathogenesis, clinical presentation, epidemiology, and comorbid associations	13
Light‐based therapies in the management of rosacea: a systematic review with meta‐analysis	13
Cutaneous adverse effects due to personal protective measures during COVID‐19 pandemic: a study of 101 patients	13
Hydroxychloroquine‐induced acute generalized exanthematous pustulosis: a series of seven patients and review of the literature	13
Depression, anxiety, and self‐esteem in women with facial melasma: an Internet‐based survey in Brazil	12
Acquired epidermodysplasia verruciformis: clinical presentation and treatment update	12
QuantiFERON TB‐gold conversion rate among psoriasis patients under biologics: a 9‐year retrospective study	12
A case of moderate hidradenitis suppurativa and psoriasis successfully treated with risankizumab	12
Allergic contact dermatitis: a significant environmental and occupational skin disease	12
The treatment of palmar hyperhidrosis – a systematic review	12
Balanopreputial sac and urine microbiota in patients with male genital lichen sclerosus	12
Erythema annulare centrifugum with anosmia and ageusia in a SARS‐CoV‐2 exposed patient successfully treated with doxycycline	12
Real‐world experience versus clinical trials: pros and cons in psoriasis therapy evaluation	12
Remote management of hidradenitis suppurativa in a pandemic era of COVID‐19	12
The effectiveness of botulinum toxin type A (BTX‐A) in the treatment of facial skin oily seborrhea, enlarged pores, and symptom complex of post‐acne	12
Acne vulgaris: role of the immune system	11
Cutaneous involvement in VEXAS syndrome: clinical and histopathologic findings	11
Skin manifestations in patients hospitalized with confirmed COVID‐19 disease: a cross‐sectional study in a tertiary hospital	11
Morphea induced by SARS‐CoV‐2 infection: A case report	11
Which are the “emergent” dermatologic practices during COVID‐19 pandemic? Report from the lockdown in Milan, Italy	11
In hyperhidrosis quality of life is even worse than in acne, eczema, or psoriasis. A comparison of Skindex‐16 and Dermatology Life Quality Index (DLQI)	11
A randomized controlled study of 6% gabapentin topical formulation for chronic kidney disease‐associated pruritus	11
Atopic dermatitis in adults: a population‐based study in Finland	11
Efficacy of high‐dose intralesional triamcinolone for hidradenitis suppurativa	11
A review of Nigella sativa plant‐based therapy in dermatology	11
Epidemiology of rosacea in a population‐based study of 161,269 German employees	11
Rescheduling of clinical activities and teleconsulting for public dermatology. Two prompt answers to COVID‐19 emergency	10
Stevens–Johnson syndrome precipitated by Moderna Inc. COVID‐19 vaccine: a case‐based review of literature comparing vaccine and drug‐induced Stevens–Johnson syndrome/t	10
Acne and diet: a review	10
A case of erythema multiforme major with multiple mucosal involvements in COVID‐19 infection	10
Melanoma in the setting of nevus of Ota: a review for dermatologists	10
Healing of deep dermal burns by allogeneic mesenchymal stromal cell transplantation	10
Biologic agents in psoriasis: our experience during coronavirus infection	10
Grover‐like skin eruption: another cutaneous manifestation in a COVID‐19 patient	10
A prospective study to assess the efficacy of various surgical modalities in treatment of stable vitiligo patches over resistant sites	10
A paradoxical head and neck erythema: an adverse event due to dupilumab in adult patients with atopic dermatitis	10
Optimizing teledermatology: looking beyond the COVID‐19 pandemic	10
Study of serum vitamin D levels in men with premature androgenetic alopecia	10
Lymphomatoid papulosis (LyP) after AZD1222 and BNT162b2 COVID‐19 vaccines	10
COVID‐19 vaccines and nanomedicine	10
COVID‐19 infection under omalizumab therapy for chronic spontaneous urticaria: three cases	10
What is the role of a dermatologist in the battle against COVID‐19? The experience from a hospital on the frontline in Milan	10
Acral edema during the COVID‐19 pandemic	10
Association between long noncoding RNA taurine‐upregulated gene 1 and microRNA‐377 in vitiligo	10
Complicated coronavirus disease 2019 (COVID‐19) in a psoriatic patient treated with ixekizumab	10
Characterization of a biofilm formed by Fusarium oxysporum on the human nails	10
Can Covid‐19 vaccines cause or exacerbate bullous pemphigoid? A report of seven cases from one center	10
Evaluation of the biostimulatory effects and the level of neocollagenesis of dermal fillers: a review	10
What is new in adult acne for the last 2 years: focus on acne pathophysiology and treatments	9
The risk of metastases from squamous cell carcinoma of the skin	9
Trichoscopic signs of tinea capitis: a guide for selection of appropriate antifungal	9
Alopecia areata and tofacitinib: a prospective multicenter study from a Saudi population	9
Review of the alternative therapies for onychomycosis and superficial fungal infections: posaconazole, fosravuconazole, voriconazole, oteseconazole	9
Primary cutaneous malignancies in nonalbino and albino Africans	9
Eruptive pseudoangiomatosis and SARS‐CoV‐2 (COVID‐19) infection	9
The clinico‐epidemiological characteristics and therapeutic experience of 152 patients with cutaneous sporotrichosis: a 10‐year retrospective study from India	9
Overlap between hemophagocytic lymphohistiocytosis and drug reaction and eosinophilia with systemic symptoms: a review	9
Recurrent varicella following SARS‐CoV‐2 vaccination with BNT162b2	9
Circulating long noncoding RNA growth arrest‐specific transcript 5 as a diagnostic marker and indicator of degree of severity in plaque psoriasis	9
Sublingual tofacitinib for alopecia areata: a roll‐over pilot clinical trial and analysis of pharmacokinetics	9
Tocilizumab‐induced sarcoidosis‐like reaction in a patient with giant cell arteritis. Clinical implications of a paradoxical phenomenon	9
Dupilumab as a useful treatment option for prurigo nodularis in an elderly patient with atopic diathesis	9
Anti‐aging effect of an oral disintegrating collagen film: a prospective, single‐arm study	9

Chronic lymphocytic leukemia and the skin: implications for the dermatologist	9
Gleich syndrome: a systematic review	9
Prevalence of ocular disease during dupilumab treatment for atopic dermatitis: a bicentric retrospective comparative cohort study	9
Cell signaling in cutaneous T‐cell lymphoma microenvironment: promising targets for molecular‐specific treatment	9
Acrofacial purpura and necrotic ulcerations in COVID‐19: a case series from New York City	8
Role of antimicrobial peptides in atopic dermatitis	8
Efficacy of hydrotherapy, spa therapy, and balneotherapy for psoriasis and atopic dermatitis: a systematic review	8
Association of Propionibacterium acnes with the efficacy of minocycline therapy for cutaneous sarcoidosis	8
A systematic review on the lipid composition of human hair	8
Serious health threat of mucormycosis during the ongoing COVID‐19 pandemic: what dermatologists need to know in this regard	8
High prevalence of autosomal recessive congenital ichthyosis in a Mexican population caused by a new mutation in the TGM1 gene: epidemiological evidence of a founder effect	8
Clinical efficacy of popular oral hair growth supplement ingredients	8
Features of oral squamous cell carcinoma in ex vivo fluorescence confocal microscopy	8
SDRIFE‐like rash in COVID‐19 patient: drug reaction or another cutaneous manifestation of SARS‐CoV‐2?	8
Post‐COVID‐19 hair loss: prevalence and associated factors among 5,891 patients	8
Leprosy: what is new	8
Clinicopathological and dermoscopic features of amelanotic and hypomelanotic melanoma: a retrospective multicentric study	8
Detection of SARS‐CoV‐2 in a case of DRESS by sulfasalazine: could there be a relationship with clinical importance?	8
Response of pityriasis rubra pilaris to brodalumab after primary failure to ustekinumab	8
Cancer risk perception predictors for total body skin examinations: a cross‐sectional study using Health Information National Trends Survey (HINTS) 2017 data	8
Pigmented onychopapilloma in Caucasians: a case series of six patients	8
Stewart‐Treves syndrome and other cutaneous malignancies in the context of chronic lymphedema: a systematic review	8
Ulcerated necrobiosis lipoidica successfully treated with tofacitinib	8
Dermatological findings in COVID‐19 patients: Mexican experience	8
Sparsity of dendritic cells and cytotoxic T cells in tumor microenvironment may lead to recurrence in basal cell carcinoma	8
Skin and eye protection against ultraviolet C from ultraviolet germicidal irradiation devices during the COVID‐19 pandemic	8
Super responders to guselkumab treatment in moderate‐to‐severe psoriasis: a real clinical practice pilot series	8
Therapeutic benefits of natural oils along with permeation enhancing activity	8
Pharmacological activation of PPAR‐γ: a potential therapy for skin fibrosis	8
Assessment of alopecia areata universalis successfully treated with upadacitinib	8
Hyperkeratosis lenticularis perstans (Flegel’s disease): our experience and review of the literature	8
Dermatology inpatient consultations in a tertiary hospital – a retrospective analysis	8
COVID‐19 and Mycoplasma pneumoniae: SARS‐CoV‐2 false positive or coinfection?	8
Deodorants and antiperspirants: identification of new strategies and perspectives to prevent and control malodor and sweat of the body	8
Localized scleroderma: actual insights and new biomarkers	8
Patient satisfaction of real‐time teledermatology: a cross‐sectional survey	7
Pseudo‐chilblain lesions and COVID‐19: a controversial relationship	7
Cutaneous squamous cell carcinoma in patients with chronic lymphocytic leukemia: a systematic review of the literature	7
Immediate response to apremilast in patients with palmoplantar pustulosis: a retrospective pilot study	7
Acetic acid and the skin: a review of vinegar in dermatology	7
UVA‐1 phototherapy as adjuvant treatment for eosinophilic fasciitis: in vitro and in vivo functional characterization	7
Chilblain‐like lesions during the COVID‐19 pandemic: early or late sign?	7
Pilot study: immunohistochemistry expressions of vitamin D receptor associated with severity of disease in psoriasis patients	7
Atypical extensive lupus tumidus‐like eruption as an early presentation of VEXAS syndrome	7
Clinico‐epidemiological profile of lichen scrofulosorum: a 22‐year, single‐center, retrospective study	7
Novel combination therapy of hydroxychloroquine and topical tacrolimus for chronic ulcerative stomatitis	7
The role of dermoscopy in the diagnosis of subungual glomus tumors	7
The stratum corneum water content and natural moisturization factor composition evolve with age and depend on body site	7
The role of prostaglandins in androgenetic alopecia	7
Trends in the epidemiology of dermatophytosis in the Middle East and North Africa region	7
Young HIV‐positive male patient with severe atopic dermatitis on dupilumab and SARS‐CoV‐2 infection, a pioneer hypothesis	7
Cutaneous reaction to BNT162b2 mRNA COVID‐19 vaccine	7
Tildrakizumab: short‐term efficacy and safety in real clinical practice	7
Skin diseases in displaced populations: a review of contributing factors, challenges, and approaches to care	7
Herpes zoster reactivation after COVID‐19 vaccination – a retrospective case series of 22 patients	7
COVID‐19‐related consequences on melanoma diagnoses from a local Italian registry in Genoa, Italy	7
Tofacitinib for refractory chilblain lupus erythematosus	7
Dermatofibrosarcoma protuberans in pregnancy: a case series and review of the literature	7
Utility of polymerase chain reaction for assessment of onychomycosis during topical therapy	7
Chilblains‐like dermatologic manifestation of COVID‐19 diagnosed by serology via multidisciplinary virtual care	7
Melanomas of the scalp: is hair coverage preventing early diagnosis?	7
Comparison of efficacy of noncultured hair follicle cell suspension and noncultured epidermal cell suspension in repigmentation of leukotrichia and skin patch in vitiligo: a randomized trial	7
Hidradenitis suppurativa is associated with hypothyroidism and hyperthyroidism: a large‐scale population‐based study	7
A prospective, randomized, split‐face study of concomitant administration of low‐dose oral isotretinoin with 30% salicylic acid chemical peeling for the treatment of acne vulgari	7
Novel mutation identified in the DDB2 gene in patients with xeroderma pigmentosum group–E	7
Hidradenitis suppurativa: a review of current treatment options	7
HLA‐B*15:11 status and carbamazepine‐induced severe cutaneous adverse drug reactions in HLA‐B*15:02 negative Chinese	7
Adoptive cell transfer (ACT) of autologous tumor‐infiltrating lymphocytes (TILs) to treat malignant melanoma: the dawn of a chimeric antigen receptor T (CAR‐T) cell therapy from autologous donor	7
Acral purpuric lesions associated with coagulation disorders during the COVID‐19 pandemic	7
Apalutamide‐induced exanthematous drug eruption displaying spongiotic dermatitis successfully treated with dose reduction	7
Secukinumab: a potential safe option in psoriasis patients affected by multiple sclerosis?	7
Perception of therapeutic inertia by patients with psoriasis in France	7
Acne in pregnancy: A prospective multicenter, cross‐sectional study of 295 patients in Turkey	7
Gluten and skin disease beyond dermatitis herpetiformis: a review	7
Skin cancers: how to balance the risks and benefits of surgery during COVID‐19 pandemic (a Northern Italy single‐center experience)	7
Dermatologic sequelae of breast cancer: From disease, surgery, and radiation	7
Inverse Gottron's papules in patients with dermatomyositis: an underrecognized but important sign for interstitial lung disease	7
Primary cutaneous melanoma risk stratification using a clinicopathologic and gene expression model: a pilot study	6
Different mitotic rates are associated with different prognostic factors, relapses, and survival rates in melanoma	6
Natural evolution in pediatric cutaneous mastocytosis: 10‐year follow‐up	6
Systemic minoxidil for hair disorders in pediatric patients: a safety and tolerability review	6
Rhinomaxillary syndrome in Hansen's disease: a clinical perspective	6
JAK inhibitors: a novel, safe, and efficacious therapy for pyoderma gangrenosum	6
Mohs surgery for early‐stage Merkel cell carcinoma (MCC) achieves local control better than wide local excision ± radiation therapy with no increase in MCC‐specific death	6
Cutaneous polyarteritis nodosa following ChAdOx1 nCoV‐19 vaccination	6
Pigmented demodicidosis ‐ an under‐recognized cause of facial hyperpigmentation	6
Serum inflammatory markers and leukocyte profiles accurately describe hidradenitis suppurativa disease severity	6
Predictors of patient experience with teledermatology in setting of COVID‐19 pandemic in a single medical center	6
Prevalence of filaggrin loss‐of‐function variants in Chilean population with and without atopic dermatitis	6
Clinicopathological analysis of primary cutaneous CD4‐positive small/medium pleomorphic T‐cell lymphoproliferative disorder: a retrospective study of 22 patients	6
Advanced malignant melanoma successfully treated with dacarbazine following anti‐PD‐1/CTLA‐4 treatment	6
Network meta‐analysis on the efficacy and safety of upadacitinib in adolescents and adults with moderate‐to‐severe atopic dermatitis	6
A novel mutation in POFUT1 gene associated with Dowling–Degos disease and hidradenitis suppurativa	6
COVID‐19 skin lesions are rarely positive at RT‐PCR test: the macrophage activation with vascular impact and SARS‐CoV‐2‐induced cytokine storm	6
One size does not fit all: the need for individualized treatment based on factors that may affect the therapeutic outcome of efinaconazole 10% solution for the treatment of toenail onychomycosis	6